Impact Factor 2024

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2633

PDF: 1361
New approved drugs for psoriatic arthritis

F.M. Perrotta, E. Lubrano

57-64

09-09-2016

https://doi.org/10.4081/reumatismo.2016.873

3113

PDF: 2194
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

143-166

31-10-2013

https://doi.org/10.4081/reumatismo.2013.143

7043

PDF: 2522
The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation

S. Russo, T. T. Mariani, R. Migliorini, A. Marcellusi, F. S. Mennini

45-56

16-09-2015

https://doi.org/10.4081/reumatismo.2015.811

2183

PDF: 1087
Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

224-232

06-11-2014

https://doi.org/10.4081/reumatismo.2014.748

2300

PDF: 1548
Intra-articular therapy with tumor necrosis factor-α antagonists: an update

S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

257-263

14-03-2014

https://doi.org/10.4081/reumatismo.2013.721

2546

PDF: 1210
Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

54-64

https://doi.org/10.4081/reumatismo.2009.54

1239

PDF: 1040
Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

57-61

16-09-2015

https://doi.org/10.4081/reumatismo.2015.823

2152

PDF: 1029
How much does an antiinflammatory treatment cost?

D. Gatti, O. Viapiana, G. Colombo, S. Adami

248-252

https://doi.org/10.4081/reumatismo.2010.248

1239

PDF: 647
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

29-01-2025

https://doi.org/10.4081/reumatismo.2025.1754

1180

PDF: 34

SUPPLEMENTARY MATERIAL: 92
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

19-12-2023

https://doi.org/10.4081/reumatismo.2023.1602

1790

PDF: 430
Italian Society of Rheumatology recommendations for the management of gout

M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bianchi, C. Borghi, M. A. Cimmino, G. M. D'Avola, G. Desideri, G. Di Giacinto, M. Govoni, W. Grassi, A. Lombardi, M. Marangella, M. Matucci Cerinic, G. Medea, R. Ramonda, A. Spadaro, L. Punzi, G. Minisola

4-21

28-03-2013

https://doi.org/10.4081/reumatismo.2013.4

5696

PDF: 1513
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

07-04-2025

https://doi.org/10.4081/reumatismo.2025.1817

1331

PDF: 386

SUPPLEMENTARY MATERIAL: 239
Safety of lornoxicam in G-6-PDH deficiency

G. Perpignano, E. Cacace, C. Matulli, V. Ruggiero

45-47

https://doi.org/10.4081/reumatismo.2003.45

759

PDF: 554
Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

41-49

https://doi.org/10.4081/reumatismo.2008.41

1160

PDF: 774
The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

L. Riente

74-79

https://doi.org/10.4081/reumatismo.2004.1s.74

745

PDF: 887
Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis

S. Bello, C. Bonali, L. Serafino, P. Di Giuseppe, A. Minosi, N. Terlizzi

46-50

https://doi.org/10.4081/reumatismo.2010.46

1085

PDF: 1306
BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

D.D. Gladman

85-87

https://doi.org/10.4081/reumatismo.2007.1s.85

623

PDF: 558
Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis

G. Biasi, L. Moltoni, C. Acciai, S. Di Martino, R. Marcolongo

145-150

https://doi.org/10.4081/reumatismo.2001.145

989

PDF: 701
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with IgG4-related disease

Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

22-01-2025

https://doi.org/10.4081/reumatismo.2025.1744

1084

PDF: 19

SUPPLEMENTARY MATERIAL: 5
Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases

H. Marotta, R. Montisci, F. Tiso, S. Pontarollo, M. Rizzo, F. Tona, S. Iliceto, F. Cozzi

299-303

https://doi.org/10.4081/reumatismo.2007.299

907

PDF: 710
Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases

R. Deniz, N. Güner, Ş.A. Ekmen, İ.N. Mutlu, D.S. Özgür, B. Karaalioğlu, G. Akkuzu, F. Yıldırım, K. Kalkan, G. Güzelant-Özköse, B. İnce, M. Erdoğan, Y. Özlük, I. Kılıçaslan, C. Bes

18-09-2023

https://doi.org/10.4081/reumatismo.2023.1586

1263

PDF: 517
Tolerability, safety and efficacy of Iloprost infusion without peristaltic pump in systemic sclerosis

M. Arreghini, P. Prudente, W. Maglione, C. Arnoldi, S. Tosi, A. Marchesoni

140-144

https://doi.org/10.4081/reumatismo.2001.140

812

PDF: 1142
Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

244-261

https://doi.org/10.4081/reumatismo.2007.244

1288

PDF: 1105
Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip

A. Migliore, S. Tormenta, L.S. Martin Martin, C. Valente, U. Massafra, A. Latini, A. Alimonti

104-109

https://doi.org/10.4081/reumatismo.2004.104

1214

PDF: 1012
Safety of anti-TNFa biological drugs

F. Trotta, G. Valentini

34-39

https://doi.org/10.4081/reumatismo.2005.4s.34

1131

PDF: 1125
Are biological drugs safe in pregnancy?

A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

304-317

31-03-2015

https://doi.org/10.4081/reumatismo.2014.798

3724

PDF: 2401
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

29-12-2022

https://doi.org/10.4081/reumatismo.2022.1511

1864

PDF: 787
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

285-303

31-03-2015

https://doi.org/10.4081/reumatismo.2014.799

2499

PDF: 2247
Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

224-235

https://doi.org/10.4081/reumatismo.2003.224

1110

PDF: 2505
Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

32-37

https://doi.org/10.4081/reumatismo.2007.32

1638

PDF: 739
The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis

S. Parisi, A. Bortoluzzi, G.D. Sebastiani, F. Conti, R. Caporali, N. Ughi, I. Prevete, A. Ariani, M. Manara, G. Carrara, C.A. Scirè

22-49

23-09-2019

https://doi.org/10.4081/reumatismo.2019.1202

7872

PDF: 2359
A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib

F.M. Mariani, A. Alunno, F. Carubbi, C. Ferri

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1620

1373

PDF: 468
TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

275-282

https://doi.org/10.4081/reumatismo.2006.275

1022

PDF: 929
Analgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis

G.P. Pasero, O. Di Munno

238-242

https://doi.org/10.4081/reumatismo.2002.238

3827
IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

62-73

https://doi.org/10.4081/reumatismo.2004.1s.62

1267

PDF: 1907
Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

U. Fiocco, P. Sfriso, F. Oliviero, F. Sovran, E. Scagliori, E. Pagnin, M. Vezzù, L. Cozzi, C. Botsios, R. Nardacchione, A. Di Maggio, L. Rubaltelli, C. Giacometti, F. Calabrese, S. Todesco

268-274

https://doi.org/10.4081/reumatismo.2006.268

1532

PDF: 2662
The treatment of recurrent uveitis with TNFα inhibitors

P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

185-189

https://doi.org/10.4081/reumatismo.2004.185

1729

PDF: 2354
Efficacy and safety of two generic copies of nimesulide in patients with low back pain or knee osteoarthritis

K.V. Ilic, M. Sefik-Bukilica, S. Jankovic, N. Vujasinovic-Stupar

27-33

https://doi.org/10.4081/reumatismo.2009.27

1485

PDF: 1105
Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice

G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini

261-267

https://doi.org/10.4081/reumatismo.2006.261

1179

PDF: 694
Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

Dario Camellino, Christian Dejaco, Franco Martini, Renzo Cosso, Gerolamo Bianchi

28-10-2024

https://doi.org/10.4081/reumatismo.2024.1796

1524

PDF: 240
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

290-295

https://doi.org/10.4081/reumatismo.2008.290

2056

PDF: 1058
The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis

I. Pantano, D. Mauro, D. Simone, L. Costa, D. Capocotta, M. Raimondo, D. Birra, G. Cuomo, T. D'Errico, M. Ferrucci, F. Comentale, G. Italiano, P. Moscato, N. Pappone, R. Russo, S. Scarpato, R. Tirri, P. Buono, A. Postiglione, R. Guida, R. Scarpa, U. Trama, E. Tirri, F. Ciccia

21-03-2023

https://doi.org/10.4081/reumatismo.2022.1528

952

PDF: 555
Percutaneous vertebroplasty as therapy of vertebral fractures: results in a series of osteoporotic patients

C.U. Manzini, L. Bernini, S. Vallone, F. Cavallari, C. Ferri

209-214

https://doi.org/10.4081/reumatismo.2007.209

897

PDF: 1024
Treatment of Wegener’s granulomatosis

V. Riccieri, G. Valesini

69-76

https://doi.org/10.4081/reumatismo.2004.69

1319

PDF: 5199
Current therapeutic strategies for HCV-associated cryoglobulinemia

F. Iannuzzella, G. Garini

163-173

https://doi.org/10.4081/reumatismo.2008.163

1029

PDF: 2001
Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

267-272

https://doi.org/10.4081/reumatismo.2005.267

1050

PDF: 1658
Psoriasis in women with psoriatic arthritis: hormonal effects, fertility, and considerations for management at different stages of life

F. Cassalia, A. Belloni Fortina

11-09-2024

https://doi.org/10.4081/reumatismo.2024.1775

2245

PDF: 902
Efficacy of immunosoppressive therapy and steroid sparing effect in interstitial lung disease associated to antisynthetase syndrome

N. Franzolini, L. Quartuccio, G. De Marchi, S. De Vita

202-208

https://doi.org/10.4081/reumatismo.2007.202

1397

PDF: 1242
Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

M.G. Portuesi, P. Perosa

61-63

https://doi.org/10.4081/reumatismo.2008.61

1154

PDF: 863

1 - 50 of 54 items 1 2 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy